ROCKVILLE, Md. (AP) 鈥� ROCKVILLE, Md. (AP) 鈥� Supernus Pharmaceuticals Inc. (SUPN) on Monday reported a loss of $58.4 million in its second quarter.
The Rockville, Maryland-based company said it had a loss of $1.01 per share. Earnings, adjusted for asset impairment costs and amortization costs, came to 54 cents per share.
The drugmaker posted revenue of $219.1 million in the period.
Supernus expects full-year revenue in the range of $860 million to $890 million.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/SUPN
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
